A Multicentre, phase IIa clinical trial to assess the safety, tolerability and pharmacodynamics of Cpn10 administered as multiple intravenous injections in volunteers with multiple sclerosis

Trial Profile

A Multicentre, phase IIa clinical trial to assess the safety, tolerability and pharmacodynamics of Cpn10 administered as multiple intravenous injections in volunteers with multiple sclerosis

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs INV 103 (Primary)
  • Indications Multiple sclerosis
  • Focus Adverse reactions
  • Sponsors Invion
  • Most Recent Events

    • 11 Oct 2007 Results have been reported at ECTRMS 2007 (1087305)
    • 06 Jul 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top